Company intelligence / Profile preview

ActiGraph

Pensacola, Florida, United Statestheactigraph.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

ActiGraph’s medical-grade wearables and digital health platforms have been deployed in over 230–250 industry-sponsored clinical drug trials and thousands of academic/public health studies. Their solutions are cited in more than 24,000 peer-reviewed publications. The company’s recent integration of AI-driven analytics enables advanced endpoints such as cough detection for respiratory diseases and objective pain assessment for oncology/immunology trials. No direct therapeutic or drug development programs; focus on enabling data capture/analysis for R&D.

Therapeutic areas: OncologyCardiovascularNeurologyOther
Modalities: DeviceSoftwareData analytics
Industry: Physiological Monitoring

Partnerships

Hyfe Inc.

Beyond the preview

Go deeper on ActiGraph.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ActiGraph.

Explore the full profile